BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37361538)

  • 21. Pregnancy outcome and cost-effectiveness comparisons of artificial cycle-prepared frozen embryo transfer with or without GnRH agonist pretreatment for polycystic ovary syndrome: a randomised controlled trial.
    Luo L; Chen M; Wen Y; Zhang L; Zhou C; Wang Q
    BJOG; 2021 Mar; 128(4):667-674. PubMed ID: 32783367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in artificial cycles: a meta-analysis.
    Li X; Lin J; Zhang L; Liu Y
    Arch Gynecol Obstet; 2023 Sep; 308(3):675-683. PubMed ID: 36266549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramuscular injection of human chorionic gonadotropin as luteal phase support in artificial cycle frozen-thawed embryo transfer does not improve clinical outcomes: a parallel, open-label randomized trial.
    Li X; Huang Y; Shi Z; Shi J; Li N
    Front Endocrinol (Lausanne); 2023; 14():1283197. PubMed ID: 38260168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF/ICSI for high responders: a randomized controlled trial.
    Santos-Ribeiro S; Mackens S; Popovic-Todorovic B; Racca A; Polyzos NP; Van Landuyt L; Drakopoulos P; de Vos M; Tournaye H; Blockeel C
    Hum Reprod; 2020 Dec; 35(12):2808-2818. PubMed ID: 32964939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles.
    Chen H; Wang Y; Lyu Q; Ai A; Fu Y; Tian H; Cai R; Hong Q; Chen Q; Shoham Z; Kuang Y
    Fertil Steril; 2015 May; 103(5):1194-1201.e2. PubMed ID: 25813280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of single dose GnRH agonist as luteal support on pregnancy outcome in frozen-thawed embryo transfer cycles: an RCT.
    Davar R; Farid Mojtahedi M; Miraj S
    Iran J Reprod Med; 2015 Aug; 13(8):483-8. PubMed ID: 26568750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intramuscular injection of human chorionic gonadotropin prior to secretory transformation in patients undergoing frozen-thawed embryo transfer cycles.
    Deng L; Chen X; Blockeel C; Ye DS; Chen SL
    Reprod Biol Endocrinol; 2020 May; 18(1):52. PubMed ID: 32450894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
    Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
    Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy and neonatal outcomes following luteal GnRH antagonist administration in patients with severe early OHSS.
    Lainas GT; Kolibianakis EM; Sfontouris IA; Zorzovilis IZ; Petsas GK; Lainas TG; Tarlatzis BC
    Hum Reprod; 2013 Jul; 28(7):1929-42. PubMed ID: 23624582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose administration of a short-acting gonadotropin-releasing hormone agonist does not affect cycle outcome in frozen-thawed embryo transfer cycles.
    Wang H; Tang X; Bukulmez O; Deng C; Yu Q; Zhou Y; Sun Z; Zhen J; Wang X; Liu M
    J Int Med Res; 2021 May; 49(5):3000605211012247. PubMed ID: 33947255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cycle regimens for frozen-thawed embryo transfer.
    Ghobara T; Gelbaya TA; Ayeleke RO
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD003414. PubMed ID: 28675921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gonadotropin-releasing hormone agonist combined with hormone replacement therapy does not improve the reproductive outcomes of frozen-thawed embryo transfer cycle in elderly patients: a retrospective study.
    Dong M; Sun L; Huang L; Yi Y; Zhang X; Tan Y; Song G; Liu L; Wei F; Liu F
    Reprod Biol Endocrinol; 2020 Jul; 18(1):73. PubMed ID: 32669123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist.
    Ji H; Su Y; Zhang M; Li X; Li X; Ding H; Dong L; Cao S; Zhao C; Zhang J; Shen R; Ling X
    Front Endocrinol (Lausanne); 2022; 13():828993. PubMed ID: 35574002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Micronized progesterone plus dydrogesterone versus micronized progesterone alone for luteal phase support in frozen-thawed cycles (MIDRONE): a prospective cohort study.
    Vuong LN; Pham TD; Le KTQ; Ly TT; Le HL; Nguyen DTN; Ho VNA; Dang VQ; Phung TH; Norman RJ; Mol BW; Ho TM
    Hum Reprod; 2021 Jun; 36(7):1821-1831. PubMed ID: 33930124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles.
    Tesarik J; Hazout A; Mendoza-Tesarik R; Mendoza N; Mendoza C
    Hum Reprod; 2006 Oct; 21(10):2572-9. PubMed ID: 16926261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of uterine, endometrial and subendometrial blood flows in predicting pregnancy outcomes between fresh and frozen-thawed embryo transfer after GnRH antagonist protocol: a retrospective cohort study.
    Yu J; Li B; Li H; Li Q; Nai Z; Deng B; Li Y
    J Obstet Gynaecol; 2023 Dec; 43(1):2195937. PubMed ID: 37029723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Live birth rates after different endometrial preparation methods in frozen cleavage-stage embryo transfer cycles: a randomized controlled trial.
    Madani T; Ramezanali F; Yahyaei A; Hasani F; Bagheri Lankarani N; Mohammadi Yeganeh L
    Arch Gynecol Obstet; 2019 Apr; 299(4):1185-1191. PubMed ID: 30707360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles.
    Hill MJ; Miller KA; Frattarelli JL
    Fertil Steril; 2010 Feb; 93(2):416-22. PubMed ID: 19171338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.